11th Postgraduate Course
for Training in
Reproductive Medicine and Reproductive Biology
Geneva WHO Collaborating Center in Human Reproduction
in collaboration with
WHO Department of Reproductive Health and Research
sponsored by
Bertarelli Foundation
Ernst Schering Research Foundation
Geneva-Yaoundé Cooperation
International Association for Maternal and Neonatal Health
Serono International
Swiss National Science Foundation
United Nations Population Fund
World Health Organization
All lectures listed here are public and can be attended by anyone interested in the field.
Lectures will be held in the Pavillon de l’Ecole de la Roseraie rue Barthélémy-Menn, 2nd floor,
or at WHO in Room M 505 (1), Room M 105) (2), salle A (3) or Room X7 (4)
LECTURE PLAN 2001
| Date | Lecturer | |||
| Sept. 3 |
09.00 |
R. Kulier (Geneva) | Presentation of the course and discussion | |
|
10.30 |
Visit of the computer room 1-914 | |||
|
15.00 |
A. Campana
(HUG) P. van Look (WHO) F. Santchi (IAMANEH) G. McDonald (UNFPA) F. Baumann (Geneva-Yaoundé Cooperation) D. Bertarelli-Späth (Bertarelli Foundation) E. Glättli (SNSF) M. Lessl (Ernst Schering Research Foundation) A. Eskhol (Serono International) |
Opening ceremony | ||
|
16.00 |
E. Diczfaluszy | Human reproduction : too much or too little ? | ||
|
17.00 |
Get-together-party (Maternity - Foyer) | |||
| Sept. 4 |
09.00 |
J. Cottingham (WHO) | Gender issues in reproductive health research | |
15.00 |
M. Serodino (Geneva) | Visit of the CMU library | ||
| Sept. 5 |
09.00 |
M. Devantery (Geneva) | Gametogenesis | |
|
10.00 |
F. Urner (Geneva) | Fertilisation | ||
|
11.00 |
E. Tribolet (Geneva) | Oxytocin in reproductive biology | ||
|
14.00 |
A. Campana (Geneva) | Medline | ||
| Sept. 6 |
09.00 |
P. Bischof (Geneva) | Implantation | |
|
10.00 |
P. Bischof (Geneva) | Implantation | ||
|
11.00 |
P. Bischof (Geneva) | Receptors | ||
| Sept. 7 |
09.00 |
R. Gaillard (Lausanne) | The hypothalamo-pituitary axis | |
|
10.00 |
F. Pralong (Lausanne) | Leptin and reproduction | ||
|
11.00 |
M. Aubert (Geneva) | Regulation of GnRH secretion | ||
| Sept. 10 |
09.00 |
J.M. Dubuis (Geneva) | Puberty | |
|
10.00 |
J.M. Dubuis (Geneva) | Puberty | ||
|
11.00 |
P. Mock (Geneva) | Menstrual cycle | ||
|
14.00 |
F. Ludicke (Geneva) | Powerpoint | ||
| Sept. 11 |
09.00 |
C. Delozier (Geneva) | Introduction to the module and to the genetics consultation | |
|
09.15 |
A.Bottani (Geneva) | Genetics counselling : principles and examples | ||
|
10.00 |
S. Dahoun (Geneva) | Chromosomal pathology : pre and postnatal diagnosis | ||
|
10.45 |
M. Morris(Geneva) | Principles of molecular diagnosis | ||
| Sept. 12 |
09.00 |
C. Delozier (Geneva) | The genetics consultation in Ob-Gyn : reproductive pathologies, prenatal diagnosis and hereditary cancers | |
|
10.30 |
S.E. Antonarakis (Geneva) | The human genome project and its implications for the practice of medicine in the 21st century | ||
|
14.00 |
C. Delozier and colleagues | Visit of the Division of Medical Genetics (2 h) | ||
| Sept. 13 |
09.00 |
M. Lindheimer (Geneva) | Renal disease and pregnancy | |
|
10.00 |
S. Nazeer (Geneva) | Sexually transmitted diseases | ||
|
11.00 |
M. Tötsch (Geneva) | Visit of the cytopathology laboratory | ||
|
14.00 |
M. Neerman (Geneva) | Genes implicated in sex differentiation | ||
| Sept. 14(1) |
09.00 |
J. Villar (WHO) | Introduction to the module | |
| J. Villar (WHO) | Type of epidemiologic clinical studies | |||
|
10.00 |
R. Kulier (Geneva) | Case-control studies | ||
|
11.00 |
M. Gülmezoglu (WHO) | Randomised controlled trials : study | ||
|
14.00 |
P. Rowe (WHO) | Intrauterine devices | ||
|
15.00 |
Visit to the WHO library | |||
| Sept. 17(2) |
09.00 |
M. Merialdi (WHO) | Cohort studies | |
|
10.00 |
M. Boulvain (Geneva) | Protocol development | ||
|
14.00 |
T. Farley (Geneva) | HIV in pregnancy | ||
| Sept. 18(2) |
09.00 |
M. Gülmezoglu (WHO) | Systematic reviews | |
|
10.00 |
M. Gulmezoglu (WHO) | The Cochrane
Library Reproductive Health Library |
||
|
11.00 |
M. Merialdi (WHO) | Screening in RH | ||
| Sept. 19(2) |
09.00 |
G. Piaggio (WHO) | Strategies for data analysis: I) Observational studies | |
|
10.00 |
G. Piaggio (WHO) | Strategies for data analysis: II) Randomised controlled studies | ||
| Sept. 20(3) |
09.00 |
R. Kulier (Geneva)/ M. Gulmezoglu (WHO) |
Critical appraisal | |
10.00 |
R. Kulier (Geneva)/ M. Gulmezoglu (WHO) |
Workshop : critical analysis of a paper | ||
|
11.00 |
J. Villar (WHO) | Expressing study results | ||
| Sept. 21(3) |
09.00 |
P. van Look (WHO) | Reproductive
Health Research at WHO |
|
|
10.00 |
H. von Hertzen (WHO) | Emergency contraception | ||
|
11.00 |
H. von Hertzen (WHO) | Induced abortion | ||
| Sept. 24(4) |
09.00 |
C. d`Arcangues (WHO) | Long acting hormonal methods | |
|
10.00 |
K. Vogelsong (WHO) | Natural contraceptive methods | ||
|
11.00 |
Y.F. Wang (WHO) | Frontiers in contraceptive development | ||
| Sept. 25(3) |
09.00 |
I. Shah (WHO), | Contraceptive prevalence | |
|
10.00 |
B. Peterson (WHO) | Medical eligibility criteria for contraceptives | ||
|
11.00 |
B. Peterson (WHO) | Female sterilisation | ||
|
14.00 |
E. Vayena (WHO) | Ethics and informed consent in research | ||
| Sept. 26(4) |
09.00 |
K. Vogelsong (WHO) | Male contraception | |
|
10.00 |
K. O'Reilly (WHO) | Barrier methods | ||
|
11.00 |
K. O'Reilly (WHO) | Dual protection | ||
| Sept. 27(4) |
09.00 |
D. Griffin (WHO) | Immunocontraception | |
|
10.00 |
M. Gulmezoglu (WHO) | Antenatal care | ||
|
11.00 |
J. Villar/A. Betran (WHO) | WHO studies on maternal morbidity in developing countries | ||
| Sept. 28 |
09.00 |
A. Campana (Geneva) | Definition, prevalence and etiology of infertility | |
|
10.00 |
A. Campana (Geneva) | Evaluation of the infertile couple | ||
|
11.00 |
A. Campana (Geneva) | Spontaneous abortion | ||
|
14.00 |
A. Campana (Geneva) | Internet | ||
| Oct. 1 |
09.00 |
D. Chardonnens (Geneva) | Medical treatment of female infertility | |
|
10.00 |
G. de Candolle (Geneva) | Surgical treatment of female infertility | ||
|
11.00 |
H. Lucas (Geneva) | Assisted reproductive technologies | ||
|
14.00 |
G. Benagiano (Geneva) | Reproductive health : a new dimension | ||
|
15.00 |
J. Philippe (Geneva) | Diabetes and reproduction | ||
| Oct. 2 |
09.00 |
R. Martin-du-Pan (Geneva) | Diagnostic methods in male infertility | |
|
10.00 |
A. de Agostini (Geneva) | Semen analysis | ||
|
11.00 |
G. de Boccard (Geneva) | Treatment of male infertility | ||
| Oct. 3 |
09.00 |
G. Girardet (Geneva) | Menopause | |
|
10.00 |
D. de Ziegler (Geneva) | Hormone replacement therapy | ||
|
11.00 |
J.-Ph. Bonjour (Geneva) | Osteoporosis | ||
| Oct. 4 |
09.00 |
P. Huppi (Geneva) | Brain development in the new-born infant | |
|
10.00 |
E. Ezcurra (WHO) | Oral contraceptives | ||
|
11.00 |
E. Ezcurra (WHO) | Risks and benefits of oral contraceptives | ||
| Oct. 5 |
09.00 |
M. Boulvain (Geneva) | Anaemia in pregnancy | |
|
10.00 |
M. Gülmezoglu (WHO) | Post partum haemorrhage | ||
|
11.00 |
O. Irion (Geneva) | Preeclampsia | ||
|
14.00 |
M. Merialdi (WHO) | Preterm labour | ||
| Oct. 8 |
09.00 |
R. Pfister (Geneva) | Neonatal examination; resuscitation in the delivery unit | |
|
10.00 |
C. Stan (Geneva) | Prevention of neonatal infections | ||
|
11.00 |
K. Kinkel (Geneva) | Imaging methods in reproductive medicine | ||
|
14.00 |
M. Morales (Geneva) | Visit of the delivery room | ||
| Oct. 9 |
09.00 |
S. Nazeer (Geneva) | Screening programmes in gynaecological cancer | |
|
10.00 |
E. Mégevand (Geneva) | Basic principles of colposcopy and dysplasia management | ||
|
11.00 |
M. Tötsch (Geneva) | Cytopathology | ||
|
14.00 |
R. Auckenthaler (Geneva) | UTI in pregnancy | ||
|
14.30 |
R. Auckenthaler (Geneva) | Diagnostic tests | ||
| Oct. 10 |
09.00 |
D. Herbert / S. Nazeer (Geneva) | Trophoblastic diseases | |
|
10.00 |
A. Major (Geneva) | Ovarian cancer | ||
|
11.00 |
G. Vlastos (Geneva) | Breast cancer and reproductive health | ||
| Oct. 15 - 17 | Exams | |||
Edited by Aldo Campana,